$VRSK

Verisk Analytics, Inc. Stock 12‑Month Price Target Cut to $232.29, Implies 31% Upside

Verisk Analytics' average price target was reduced by analysts from $233.47 to $232.29, suggesting a 31% upside from its Oct. 12 closing price. The consensus rating remains 'Buy' among 23 analysts.

Original reporting
Published Oct 13, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Verisk Analytics, Inc. Stock 12‑Month Price Target Cut to $232.29, Implies 31% Upside — source image
Decision brief

The 30-second read

$VRSKBearishLow
01

Why it matters

The slight downward revision may lead to short‑term price pressure, but the overall upside potential remains sizable given the implied 31% upside from the current price.

02

Market read

A modest analyst target cut is a low‑impact catalyst, offering limited trading opportunities.

03

What to watch

Potential upside from upcoming underwriting cycles or new data‑product launches not yet reflected in analyst models.

Relevance 5/10Novelty 5/10Timing: today

Background

Verisk Analytics provides data and analytics to insurance, energy, and financial services firms. Analyst price‑target revisions are a routine metric of market expectations.

Company-level read

Ticker impact

$VRSKBearishHigh confidence
Context

Analyst consensus price target for Verisk Analytics was lowered to $232.29, down from $233.47, indicating a fresh downgrade in expectations.

Expected impact

potential downside as the market prices in the lower target

Evidence & confidence

Analyst price‑target revisions are a direct catalyst; a cut signals reduced earnings expectations and can trigger sell pressure.

Market effects

Minor impact on the data‑analytics and insurance‑services sector as peers may see similar target revisions.

U.S. market focus; no broader regional effect.

Limited to investors tracking Verisk and related insurance‑tech stocks.

Counterpoint

Some investors may view the modest target cut as an overreaction and look for buying opportunities if the stock is oversold.

Key entities

  • Verisk Analytics, Inc.

    U.S. data‑analytics firm (ticker VRSK).

Related articles

$VRSKHighAI 8/10

RBC Capital reiterates Verisk Analytics stock rating at Outperform

RBC Capital reiterated an Outperform rating and $230 price target for Verisk Analytics (VRSK) after a court ruling on its AccuLynx acquisition. The Delaware Supreme Court ordered Verisk to pursue FTC approval and close the $2.35B deal, awarding AccuLynx costs. Verisk will comply, with the transaction subject to FTC review. The deal may constrain share buybacks and increase leverage. Verisk's Q2 earnings and revenue slightly beat estimates, and BMO Capital raised its price target to $248.

$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).